Last $26.46 USD
Change Today +1.67 / 6.74%
Volume 1.2M
AUXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:00 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James E. Fickenscher

Chief Financial Officer and Principal Accounting Officer, Auxilium Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$1,394,460
As of Fiscal Year 2013

Background*

Mr. James E. Fickenscher has been the Chief Financial Officer of Auxilium Pharmaceuticals Inc. since May 18, 2005 and serves as its Chief Accounting Officer. Mr. Fickenscher joined Aventis Berhing in 1995 as Vice President, Business Development and Strategic Planning. He has held the following positions at Aventis Berhing: General Manager, Japan; Vice President & General Manager, Hemophilia Business Unit and from 2000 until 2004, Senior Vice President, Chief Financial ...

Read Full Background

Corporate Headquarters*

640 Lee Road
Chesterbrook, Pennsylvania 19087

United States

Phone: 484-321-5900
Fax: 484-321-5999

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Bloomsburg University Of Pennsylvania

Other Affiliations*

Annual Compensation*

Salary$383,885
Total Annual Compensation$383,885

Stock Options*

Restricted Stock Awards$433,710
All Other Compensation$5,449
Exercised Options Value$1,107,750
Exercisable Options Value$1,090,685
Unexercisable Options Value$143,280
Total Value of Options$2,341,715

Total Compensation*

Total Annual Cash Compensation$632,032
Total Short Term Compensation$383,885
Other Long Term Compensation$439,159
Total Calculated Compensation$1,394,460
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AUXL:US $26.46 USD +1.67

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv De Silva Chief Executive Officer, President and Director
Endo International plc
--
Paul M. Bisaro Chairman, Chief Executive Officer and President
Actavis plc
$2.6M
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Antares Pharma Inc.
$477.0K
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AUXILIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.